Paul E. Borchardt

1.0k total citations
17 papers, 812 citations indexed

About

Paul E. Borchardt is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Paul E. Borchardt has authored 17 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Pathology and Forensic Medicine and 2 papers in Surgery. Recurrent topics in Paul E. Borchardt's work include Radiopharmaceutical Chemistry and Applications (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Paul E. Borchardt is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). Paul E. Borchardt collaborates with scholars based in United States. Paul E. Borchardt's co-authors include Michael R. McDevitt, David A. Scheinberg, Matthias Miederer, Karen Wu, Lawrence Lai, Michael Curcio, Jim Simón, Neil H. Bander, Dangshe Ma and R. Keith Frank and has published in prestigious journals such as Science, Biochemistry and Clinical Cancer Research.

In The Last Decade

Paul E. Borchardt

16 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul E. Borchardt United States 10 623 238 187 125 68 17 812
M W Brechbiel United States 15 859 1.4× 294 1.2× 269 1.4× 255 2.0× 86 1.3× 24 1.1k
Klaus A. Hamacher United States 11 686 1.1× 309 1.3× 175 0.9× 99 0.8× 40 0.6× 13 864
Anaira C. Clavo United States 11 636 1.0× 292 1.2× 234 1.3× 172 1.4× 44 0.6× 16 1.2k
R. Keith Frank United States 9 596 1.0× 218 0.9× 153 0.8× 87 0.7× 24 0.4× 12 730
Patrizia Magnani Italy 18 524 0.8× 151 0.6× 172 0.9× 139 1.1× 50 0.7× 39 883
Philippe Thédrez France 17 464 0.7× 92 0.4× 120 0.6× 100 0.8× 48 0.7× 31 617
Mickaël Bourgeois France 22 648 1.0× 200 0.8× 319 1.7× 189 1.5× 59 0.9× 45 996
Jacqueline Emrich United States 15 361 0.6× 134 0.6× 217 1.2× 231 1.8× 51 0.8× 34 822
C. Curtet France 17 557 0.9× 97 0.4× 170 0.9× 150 1.2× 62 0.9× 36 880
Sébastien Gouard France 18 450 0.7× 178 0.7× 259 1.4× 159 1.3× 87 1.3× 37 758

Countries citing papers authored by Paul E. Borchardt

Since Specialization
Citations

This map shows the geographic impact of Paul E. Borchardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Borchardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Borchardt more than expected).

Fields of papers citing papers by Paul E. Borchardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Borchardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Borchardt. The network helps show where Paul E. Borchardt may publish in the future.

Co-authorship network of co-authors of Paul E. Borchardt

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Borchardt. A scholar is included among the top collaborators of Paul E. Borchardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Borchardt. Paul E. Borchardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sipior, Janice C., James L. Bierstaker, Paul E. Borchardt, & Burke T. Ward. (2018). A Ransomware Case for Use in the Classroom. Communications of the Association for Information Systems. 43. 598–614. 6 indexed citations
2.
Borchardt, Paul E., et al.. (2005). Pharmacogenomics: An In-House Advantage?. 2(5). 1 indexed citations
3.
Ballangrud, Åse, Stig Palm, Richard M. Enmon, et al.. (2004). Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids. Clinical Cancer Research. 10(13). 4489–4497. 89 indexed citations
4.
Borchardt, Paul E., Huibert M. Vriesendorp, Ralph S. Freedman, & Syed M. Quadri. (2004). Intralesional Radioimmunotherapy with Yttrium-90-Labeled Human Monoclonal IgM in Nude Mice Bearing Human Tumor Xenografts. Cancer Biotherapy and Radiopharmaceuticals. 19(1). 43–51. 1 indexed citations
5.
Miederer, Matthias, Michael R. McDevitt, Paul E. Borchardt, et al.. (2004). Treatment of Neuroblastoma Meningeal Carcinomatosis with Intrathecal Application of α-Emitting Atomic Nanogenerators Targeting Disialo-Ganglioside GD2. Clinical Cancer Research. 10(20). 6985–6992. 42 indexed citations
6.
Borchardt, Paul E., Rui Yuan, Matthias Miederer, Michael R. McDevitt, & David A. Scheinberg. (2003). Targeted actinium-225 in vivo generators for therapy of ovarian cancer.. PubMed. 63(16). 5084–90. 132 indexed citations
7.
McDevitt, Michael R., Dangshe Ma, Lawrence Lai, et al.. (2001). Tumor Therapy with Targeted Atomic Nanogenerators. Science. 294(5546). 1537–1540. 381 indexed citations
8.
Borchardt, Paul E., Syed M. Quadri, Ralph S. Freedman, & Huibert M. Vriesendorp. (2000). Intraperitoneal Radioimmunotherapy with Human Monoclonal IGM in Nude Mice with Peritoneal Carcinomatosis. Cancer Biotherapy and Radiopharmaceuticals. 15(1). 53–64. 24 indexed citations
9.
Lai, Jing, et al.. (1999). Pharmacokinetics of radiolabeled polyclonal antiferritin in patients with Hodgkin's disease.. PubMed. 5(10 Suppl). 3315s–3323s. 7 indexed citations
10.
Vriesendorp, H. M., et al.. (1999). Fractionated radiolabeled antiferritin therapy for patients with recurrent Hodgkin's disease.. PubMed. 5(10 Suppl). 3324s–3329s. 24 indexed citations
11.
Vriesendorp, Huibert M., Syed M. Quadri, & Paul E. Borchardt. (1998). Tumour Therapy with Radiolabelled Antibodies. BioDrugs. 10(4). 275–293. 9 indexed citations
12.
Hayakawa, Kazuhiro, et al.. (1998). Microglial cytokine gene induction after irradiation is affected by morphologic differentiation.. PubMed. 15(6). 405–10. 15 indexed citations
13.
Borchardt, Paul E., Syed M. Quadri, Ralph S. Freedman, & Huibert M. Vriesendorp. (1998). Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.. PubMed. 39(3). 476–84. 11 indexed citations
14.
Borchardt, Paul E., Syed M. Quadri, Ralph S. Freedman, & Huibert M. Vriesendorp. (1997). Intralesional radiolabeled human monoclonal IgM in human tumor xenografts. Radiotherapy and Oncology. 44(3). 283–293. 5 indexed citations
15.
Borchardt, Paul E.. (1997). Radiolabeled human monoclonal IgM for intracompartmental cancer therapy. DigtalCommons @ Texas Medical Center Library (Texas Medical Center). 2 indexed citations
16.
Kohr, William J., B M Fendly, Steven J. Shire, et al.. (1992). Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor .alpha. induced receptor aggregation. Biochemistry. 31(4). 1134–1141. 62 indexed citations
17.
Borchardt, Paul E., et al.. (1961). A Rapid Semimicromethod for the Determination of Phosphorus and Barium in Biologic Preparations. Clinical Chemistry. 7(4). 264–267. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026